Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: A prospective cohort study

Atherosclerosis

Volumn 191, Issue 1, 2007, Pages 182-190

  Onat, Altan ^a   Uyarel, Hüseyin ^b   Hergenç, Gülay ^c   Karabulut, Ahmet ^b   Albayrak, Sinan ^d   Can, Günay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^d ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Abdominal obesity; Cigarette smoking; Coronary heart disease; Diabetes mellitus; Hypertension; Metabolic syndrome; Proinflammatory state

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; ATHEROGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FOLLOW UP; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SMOKING; TURKEY;

EID: 33846922552     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.03.012     Document Type: Article

References (29)

1. Wang Y., Rimm E.B., Stampfer M.J., Willett W.C., and Hu F.B. Comparison of abdominal obesity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81 (2005) 555-563
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
3. Park S.H., Lee W.Y., Rhee E.J., et al. The relative risks of metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin Sci 108 (2005) 553-559
4. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 366 (2005) 1059-1062
5. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
6. Onat A., Ceyhan K., Başar O., et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
7. Onat A., Avci{dotless} G.S., Şenocak M., Örnek E., and Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidem Commun Health 46 (1992) 470-476
8. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care 20 Suppl (1997) S1-S70
9. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostatic model assessment: insulin resistance and b-cell function from fasting glucose and insulin concentration in man. Diabetologia 28 (1985) 412-419
10. Onat A., Avci{dotless} G.S., Barlan M.M., et al. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 28 (2004) 1018-1025
11. Rose G.A., Blackburn H., Gillum R.F., and Prineas R.J. Cardiovascular survey methods. 2nd ed. (1982), WHO, Geneva pp. 124-127
12. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
13. Onat A., Sansoy V., Yi{dotless}ldi{dotless}ri{dotless}m B., et al. C-reactive protein and coronary heart disease in Western Turkey. Am J Cardiol 88 (2001) 601-607
14. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104 (2001) 145-150
15. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
16. Than T.S., Sattar N., Williams K., et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25 (2002) 2016-2021
17. Cifkova R., Frohlich J., Skodova Z., et al. C-reactive protein and the risk of developing the metabolic syndrome. A population study. Eur Heart J 26 Suppl (2005) 445 (abstr.)
18. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
19. Onat A, Hergenç G, Türkmen S, Yazi{dotless}ci{dotless} M, Sari{dotless} İ, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006;55:445-52.
20. Filozof C., Fernandez Pinilla M.C., and Fernandez-Cruz A. Smoking cessation and weight gain. Obes Rev 5 (2004) 95-103
21. Czernichow S., Bertrais S., Preziosi P., et al. Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity. Diabetes Metab 30 (2004) 110-111
22. Merchant A.T., Anand S.S., Vuksan V., et al. Protein intake is inversely associated with abdominal obesity in a multi-ethnic population. J Nutr 135 (2005) 1196-1201
23. Ishizaka N., Ishizaka Y., Toda E.-I., Nagai R., and Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25 (2005) 1038-1044
24. Mahley R.W., Palaoǧlu E., Atak Z., et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36 (1995) 839-859
25. Onat A., Hergenç G., Sari{dotless} I., et al. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study. Am J Hypertens 18 (2005) 409-416
26. Hayashi T., Boyko E.J., Leonetti D.L., et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 108 (2003) 1718-1723
27. Rexrode K.M., Buring J.E., and Manson J.E. Abdominal total adiposity and risk of coronary heart disease in men. Int J Obes 25 (2001) 1047-1056
28. Dagenais G.R., Yi Q., Mann J.F.E., et al. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 149 (2005) 54-60
29. Bigaard J., Tjonneland A., Thomsen B.L., et al. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 11 (2003) 895-903